| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |